|
Venmax Drugs & Pharmaceuticals Ltd.
|
QUARTERLY RESULTS
|
|
|
You can view the
Quaterly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
14.56 Cr.
|
P/BV
|
-22.06
|
Book Value (Rs.)
|
-1.26
|
|
52 Week High/Low (Rs.)
|
37/9
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
21/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 1.32 | 1.21 | 0.33 | 0.20 | 0.17 |
| Total Income From Operations | 1.32 | 1.21 | 0.33 | 0.20 | 0.17 |
| Purchase of Traded Goods | 2.58 | 1.12 | 0.33 | 0.22 | 0.20 |
| Increase/Decrease in Stocks | -1.44 | -0.03 | -0.06 | 0.00 | 0.00 |
| Employees Cost | 0.06 | 0.05 | 0.03 | 0.01 | 0.00 |
| Other Expenses | 0.07 | 0.03 | 0.28 | 0.47 | 0.27 |
| Total Expenses | 1.27 | 1.17 | 0.58 | 0.69 | 0.47 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 0.05 | 0.04 | -0.25 | -0.50 | -0.30 |
| Other Income | 0.00 | 0.00 | 1.02 | 0.00 | 0.00 |
| P/L Before Interest, Excpt. Items & Tax | 0.05 | 0.04 | 0.77 | -0.50 | -0.30 |
| P/L Before Exceptional Items & Tax | 0.05 | 0.04 | 0.77 | -0.50 | -0.30 |
| P/L Before Tax | 0.05 | 0.04 | 0.77 | -0.50 | -0.30 |
| Tax | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| P/L After Tax from Ordinary Activities | 0.02 | 0.04 | 0.78 | -0.50 | -0.30 |
| Net Profit/Loss For the Period | 0.02 | 0.04 | 0.78 | -0.50 | -0.30 |
| | | | | | |
| Equity Share Capital | 8.01 | 5.24 | 5.24 | 5.24 | 5.24 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 0.05 | 0.07 | 1.48 | -0.95 | -0.58 |
| Diluted EPS (Rs.) | 0.05 | 0.07 | 1.48 | -0.95 | -0.58 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 0.05 | 0.07 | 1.48 | -0.95 | -0.58 |
| Diluted EPS (Rs.) | 0.05 | 0.07 | 1.48 | -0.95 | -0.58 |
| | | | | | |
| PBITOE Margin (%) | 3.47 | 3.09 | -74.60 | -248.69 | -177.17 |
| PBTE Margin (%) | 3.42 | 3.09 | 232.84 | -248.69 | -177.64 |
| PBT Margin (%) | 3.42 | 3.09 | 232.84 | -248.69 | -177.64 |
| PAT Margin (%) | 1.85 | 3.09 | 233.83 | -248.59 | -177.72 |
